Table 1.
Characterization and clinical description of study participants.
| Descriptors | Allergic (number) | Healthy (number) |
|---|---|---|
| Sample | 18 (46.15%) | 21 (53.85%) |
| Gender distribution | 9 ♂ | 10 ♂ |
| 9 ♀ | 11 ♀ | |
| Asthma | 4 | – |
| Total IgE > 100 IU/ml | 10 | 1 |
| Doctor-diagnosed allergies | 18 | – |
| Grass pollen | 8 | – |
| Birch pollen | 13 | – |
| House dust mite | 12 | – |
| Additional other allergens | 10 | – |
| Allergic rhinitis symptomsa | 6 | – |
| Self-reported perception of symptom severityb | 5 | – |
a
Patients reporting to currently suffer from at least 3 typical rhinitis symptoms (sneezing, nasal pruritus, airflow obstruction or nasal discharge; Wheatley & Togias, 2015).
b
Numbers of patients with a self-reported perception of current allergic rhinitis symptoms > 3, on a likert-type scale ranging from 1 (minimal) to 5 (maximal symptom level).